A positive association between topical corticosteroid use and risk of type 2 diabetes mellitus has been reported in a large European population-based study. However, the increase in risk is small and should not influence the prescribing of topical corticosteroids when clinically indicated.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
National Institute for Health and Care Excellence. Clinical knowledge summaries. Corticosteroids — oral. NICE https://cks.nice.org.uk/corticosteroids-oral#!scenarioRecommendation:3 (2017).
Andersen, Y. M. F. et al. Association between topical corticosteroid use and type 2 diabetes in two European population-based adult cohorts. Diabetes Care https://doi.org/10.2337/dc18-2158 (2019).
Reynolds, R. M. et al. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur. J. Endocrinol. 166, 861–868 (2012).
Krejci-Manwaring, J. et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J. Am. Acad. Dermatol. 54, S235–S236 (2006).
Lin, L.-K. et al. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res. Care 5, e000429 (2017).
Donnelly, L. A., Morris, A. D. & Evans, J. M. M. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 100, 345–350 (2007).
Leong, A. et al. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care 36, 3002–3008 (2013).
Geer, E. B., Islam, J. & Buettner, C. Mechanisms of glucocorticoid-induced insulin resistance. Endocrinol. Metab. Clin. North Am. 43, 75–102 (2014).
Hengge, U. R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54, 1–15 (2006).
Milyani, A. A. & Al-Agha, A. E. Implication of topical steroids in the onset of osteoporosis. Case Rep. Pediatr. 2018, 4802172 (2018).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johns, E.C., Reynolds, R.M. Topical glucocorticoids and risk of type 2 diabetes mellitus. Nat Rev Endocrinol 15, 379–380 (2019). https://doi.org/10.1038/s41574-019-0212-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-019-0212-8